Oncolytics Biotech, Inc.

-0.11 (-3.77%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Oncolytics Biotech, Inc. Stock, NASDAQ:ONCY

1167 Kensington Crescent NW, Suite 210, Calgary, Alberta T2N 1X7
Phone: +1.403.670.7377
Number of Employees: 25


Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.